Quantitative Investment Management LLC Takes $607,000 Position in Bath & Body Works, Inc. $BBWI

Key Points

• Quantitative Investment Management LLC invested approximately $607,000 in Bath & Body Works, acquiring 20,028 shares during the first quarter.
• The company recently announced a quarterly dividend of $0.20 per share, indicating a dividend yield of 2.6% and a payout ratio of 21.33%.
• Analysts have mixed ratings on Bath & Body Works, with an average target price of $42.06 and ratings ranging from "overweight" to "hold" among different firms.

Quantitative Investment Management LLC acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 20,028 shares of the company's stock, valued at approximately $607,000.

Several other hedge funds have also recently bought and sold shares of BBWI. Wealth Enhancement Advisory Services LLC lifted its position in shares of Bath & Body Works by 38.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock worth $1,265,000 after purchasing an additional 11,681 shares in the last quarter. Kovitz Investment Group Partners LLC acquired a new position in Bath & Body Works in the fourth quarter worth $258,000. Merit Financial Group LLC bought a new stake in Bath & Body Works in the first quarter valued at $714,000. Nuveen Asset Management LLC lifted its stake in Bath & Body Works by 3.7% in the fourth quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock valued at $29,628,000 after buying an additional 27,136 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in Bath & Body Works by 3,642.2% in the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock valued at $50,062,000 after buying an additional 1,606,988 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 6.6%

Shares of NYSE:BBWI traded down $2.08 during trading on Thursday, hitting $29.47. 17,266,529 shares of the company's stock traded hands, compared to its average volume of 4,970,217. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87. The company has a market cap of $6.24 billion, a price-to-earnings ratio of 7.86, a price-to-earnings-growth ratio of 1.06 and a beta of 1.54. The company has a 50-day moving average price of $30.61 and a 200-day moving average price of $30.86.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same quarter last year, the firm earned $0.37 EPS. Bath & Body Works's revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works's dividend payout ratio is currently 21.33%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. JPMorgan Chase & Co. raised their target price on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. UBS Group lifted their price target on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research note on Tuesday, May 20th. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Barclays dropped their price objective on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a report on Friday, May 30th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Bath & Body Works has an average rating of "Moderate Buy" and an average price target of $42.53.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.